Kramer Robert
SEC CIK 1380956 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | Pres, CEO, Dir | 506.1K | — | — | 11 | 2022-02-22 | 2023-06-09 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Kramer Robert made no open-market trades at EBS in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-13 | 2023-06-09 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +212.3K | 506.1K | +72% | $0 |
| DM | 2023-03-06 | 2023-03-02 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +57.7K | 255.3K | +29% | $0 |
| 2023-03-02 | 2023-02-28 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | F - Tax | $12.38 | -3,226 | 103.3K | -3% | -$39.9K | |
| M | 2023-02-27 | 2023-02-23+ | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | F - Tax | $13.99 | -3,019 | 106.5K | -3% | -$42.2K |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +278 | 114.5K | +0.2% | $0 | |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | F - Tax | $13.25 | -4,944 | 109.5K | -4% | -$65.5K | |
| DM | 2022-03-02 | 2022-03-01 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +89.4K | 193.1K | +86% | $0 |
| D | 2022-03-02 | 2022-02-28 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | F - Tax | $39.64 | -1,715 | 247.0K | -0.7% | -$68.0K |
| M | 2022-02-25 | 2022-02-23+ | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | F - Tax | $42.37 | -3,453 | 159.3K | -2% | -$146.3K |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | A - Grant | $0.00 | +4,264 | 167.3K | +3% | $0 | |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | Kramer Robert | Pres, CEO, Dir | F - Tax | $42.23 | -4,595 | 162.7K | -3% | -$194.0K |
Purchase Sale Sale after option exercise All abbreviations